-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Education Program

Saturday, December 9, 2023

Saturday | Sunday | Monday | top

9:30 AM-10:45 AM

Acquired Hemophilia A Diagnosis and Management
Are We Personalizing MDS Therapy in 2023?
CAR T Cells in ALL: Bridge or Definitive Therapy?
How Do We Calibrate Cellular Therapy for Lymphoma in 2023?
What are Treatment Options for Patients with Relapsed, Refractory or Persistent AML?

2:00 PM-3:15 PM

How Do We Extend Survival for Patients with Chronic Lymphocytic Leukemia (CLL) in 2023?
Inherited Bone Marrow Failure Syndromes - From Pediatrics to Adult
Ongoing Challenges in the Management of VTE
Transfusion Support in Sickle Cell Disease

4:00 PM-5:15 PM

Graft Versus Host Disease: Is an Ounce of Prevention Worth a Pound of Cure?
Hematologic Toxicity of Immunotherapies
How is the Management Paradigm Evolving for Hodgkin Lymphoma in 2023?
Why Am I Getting Paged at 2AM? Microangiopathic Emergencies

Sunday, December 10, 2023

Saturday | Sunday | Monday | top

9:30 AM-10:45 AM

Goldilocks and Transplant Timing in Inherited Marrow Failure Syndromes: Too Early, Too Late, Just Right?
Hemostasis in Patients With Severe Liver Disease
How Do We Enhance Results in Rare Hematologic Malignancies?
How Do We Improve Outcomes in Relapsed and Refractory Multiple Myeloma in 2023?
The Iron Revolution!
What Are the Advances in Myeloproliferative Neoplasms Affecting Management?

4:30 PM-5:45 PM

Have We Optimized Therapy Yet for Patients with AML?
Hematologists and the Care of Pregnant Women
Hot Topics in Blood Donation: Donor Risks and Social Justice
How Do We Tackle Remaining Clinical Challenges in CML?

Monday, December 11, 2023

Saturday | Sunday | Monday | top

10:30 AM-11:45 AM

Energizing the Red Cell: Pyruvate Kinase Activators for Treatment of Hereditary Hemolytic Anemias
How Do We Apply T-Cell Redirection Therapy for Multiple Myeloma? CAR T-Cells and Bispecific Antibodies

2:45 PM-4:00 PM

Not Kids Anymore and Not Adults Yet: How Do We Treat Adolescent and Young Adult (AYA) Patients With ALL?
What Makes a Good Transplant Recipient? Putting the Puzzle Pieces Together

4:30 PM-5:45 PM

Alphabet Soup - Challenging Consults on the Pediatric Units
Hematologists as Lifesavers: Inpatient Hematology Emergencies
How Can We Manage High-Risk Hematologic Malignancies in the Community?
Improving Outcomes for Individuals With Sickle Cell Disease: Are We Moving the Needle?